BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 15,325 shares, a growth of 267.9% from the January 15th total of 4,166 shares. Based on an average daily trading volume, of 60,328 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily trading volume, of 60,328 shares, the days-to-cover ratio is presently 0.3 days.

BriaCell Therapeutics Stock Up 8.5%

Shares of BCTXW opened at $0.01 on Thursday. BriaCell Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25. The stock has a 50 day simple moving average of $0.03 and a two-hundred day simple moving average of $0.04.

About BriaCell Therapeutics

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on the development of novel immunotherapeutic treatments for breast cancer and other solid tumors. The company’s research strategy centers on harnessing the body’s immune system to recognize and attack cancer cells, with an emphasis on off-the-shelf allogeneic platforms that can be readily administered without the need for patient-specific manufacturing.

The company’s lead candidate, Bria-IMT, is derived from a human breast tumor cell line engineered to express immune-stimulatory molecules designed to trigger both innate and adaptive anti-tumor responses.